![DPD-dependent inactivation of 5-FU and effects of DPD deficiency. For... | Download Scientific Diagram DPD-dependent inactivation of 5-FU and effects of DPD deficiency. For... | Download Scientific Diagram](https://www.researchgate.net/publication/233825437/figure/fig2/AS:202635266269192@1425323420768/DPD-dependent-inactivation-of-5-FU-and-effects-of-DPD-deficiency-For-abbreviations-see.png)
DPD-dependent inactivation of 5-FU and effects of DPD deficiency. For... | Download Scientific Diagram
![Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time - ScienceDirect Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0011393X17300760-gr1.jpg)
Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time - ScienceDirect
![Cancers | Free Full-Text | Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy Cancers | Free Full-Text | Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy](https://www.mdpi.com/cancers/cancers-14-03207/article_deploy/html/images/cancers-14-03207-g001-550.jpg)
Cancers | Free Full-Text | Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy
![Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity | Pharmacogenomics Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.11.72/asset/images/medium/figure1.gif)
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity | Pharmacogenomics
![Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene | British Journal of Cancer Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6600208/MediaObjects/41416_2002_Article_BF6600208_Fig1_HTML.gif)
Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene | British Journal of Cancer
![Frontiers | DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice Frontiers | DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice](https://www.frontiersin.org/files/Articles/498692/fphar-10-01609-HTML/image_m/fphar-10-01609-t001.jpg)
Frontiers | DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice
![Figure 1 from Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared Figure 1 from Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared](https://d3i71xaburhd42.cloudfront.net/8d68e4ec8e7c85f1c1e4edcd5ff215ec925fe92c/3-Figure1-1.png)
Figure 1 from Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared
![Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12 - Kuilenburg - Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12 - Kuilenburg -](https://onlinelibrary.wiley.com/cms/asset/7e21f7e2-173a-4c37-96ce-9d191b36bb2b/humu23538-fig-0001-m.jpg)
Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12 - Kuilenburg -
![Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/14622416.8.3.257/asset/images/medium/graphic4.gif)
Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics
![DPD status and fluoropyrimidines-based treatment: high activity matters too | BMC Cancer | Full Text DPD status and fluoropyrimidines-based treatment: high activity matters too | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06907-0/MediaObjects/12885_2020_6907_Fig2_HTML.png)